Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Cervical Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00523432
What this trial is testing

A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies

Who this might be right for
Genital Neoplasms, Female
University of Chicago 15
Not applicableStudy completedNCT01098630
What this trial is testing

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Uterine Corpus Sarcoma+15 more
Gynecologic Oncology Group 778
Testing effectiveness (Phase 2)Study completedNCT00137475
What this trial is testing

Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function

Who this might be right for
Head and Neck Cancer
AHS Cancer Control Alberta 130
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Early research (Phase 1)Ended earlyNCT00080028
What this trial is testing

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerOropharynx CancerLarynx Cancer+1 more
Pharmacyclics LLC. 18
Not applicableLooking for participantsNCT06533267
What this trial is testing

Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal CarcinomaIntensity Modulated RadiotherapySurgery
Sun Yat-sen University 442
Early research (Phase 1)Ended earlyNCT02254044
What this trial is testing

Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus

Who this might be right for
Carcinoma, Squamous Cell
Boehringer Ingelheim 7
Testing effectiveness (Phase 2)Study completedNCT00281736
What this trial is testing

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Who this might be right for
Esophageal CancerPrecancerous Condition
Roswell Park Cancer Institute 60
Early research (Phase 1)UnknownNCT03552406
What this trial is testing

Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
ISU Abxis Co., Ltd. 33
Testing effectiveness (Phase 2)WithdrawnNCT05668949
What this trial is testing

Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT01986426
What this trial is testing

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

Who this might be right for
CancerMelanomaBreast Cancer+3 more
Lytix Biopharma AS 80
Testing effectiveness (Phase 2)Study completedNCT04287868
What this trial is testing

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

Who this might be right for
Cervical CancerHPV CancersAnal Cancer+2 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Study completedNCT03650764
What this trial is testing

Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine 43
Testing effectiveness (Phase 2)Study completedNCT01054625
What this trial is testing

Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Who this might be right for
Head and Neck Cancer
Genmab 31
Early research (Phase 1)Looking for participantsNCT06469008
What this trial is testing

BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomasSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 21
Large-scale testing (Phase 3)Study completedNCT03370367
What this trial is testing

Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer

Who this might be right for
Stage I-II Head and Neck Cancer
Eastern Cooperative Oncology Group 189
Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)UnknownNCT03024489
What this trial is testing

Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerLocally Advanced
Mahidol University 27
Early research (Phase 1)Ended earlyNCT01283178
What this trial is testing

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

Who this might be right for
Salivary Gland Squamous Cell CarcinomaStage II Salivary Gland CancerStage II Squamous Cell Carcinoma of the Hypopharynx+13 more
Virginia Commonwealth University 3
Testing effectiveness (Phase 2)Study completedNCT00030576
What this trial is testing

Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University Health Network, Toronto 51
Next Page